Bausch Health Companies Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BHC New York 2830 www.bauschhealth.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bausch Health Companies Inc.

Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia - Aug 31st, 2026 4:00 pm
Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners - Aug 27th, 2026 6:02 am
Can Bausch (BHC) Run Higher on Rising Earnings Estimates? - Aug 21st, 2026 10:20 am
Bausch (BHC) Upgraded to Buy: Here's What You Should Know - Aug 21st, 2026 10:00 am
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners - Aug 17th, 2026 6:00 am
Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month - Aug 10th, 2026 2:26 pm
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - Aug 6th, 2026 5:04 am
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance - Aug 6th, 2026 5:00 am
Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook - Jul 30th, 2026 10:03 pm
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised - Jul 30th, 2026 10:33 am
Bausch Health Companies Inc. Q2 2026 Earnings Call Summary - Jul 30th, 2026 6:30 am
Bausch Health Cos Q2 Earnings Call Highlights - Jul 29th, 2026 7:04 pm
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates - Jul 29th, 2026 6:35 pm
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say - Jul 29th, 2026 5:30 pm
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE - Jul 29th, 2026 2:05 pm
(Pr)ELIDEL® (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan for Eligible Patients with Mild to Moderate Atopic Dermatitis - Jul 28th, 2026 6:00 am